Find out more about a powerful Android-running E-Ink tablet with stylus support and more in this BOOX Note Air 4C review.

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults.

Nuvalent chases after Nuvation in ROS1 lung cancer. New trial data sets up a filing for Nuvalent's new-generation ROS1 inhibitor in NSCLC, although it has an uphill battle to catch rival Nuvation.